Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

The phosphocholine-binding pocket on C-reactive protein is necessary for initial protection of mice against pneumococcal infection.

Gang TB, Hammond DJ Jr, Singh SK, Ferguson DA Jr, Mishra VK, Agrawal A.

J Biol Chem. 2012 Dec 14;287(51):43116-25. doi: 10.1074/jbc.M112.427310. Epub 2012 Nov 8.

2.

C-reactive protein protects mice against pneumococcal infection via both phosphocholine-dependent and phosphocholine-independent mechanisms.

Gang TB, Hanley GA, Agrawal A.

Infect Immun. 2015 May;83(5):1845-52. doi: 10.1128/IAI.03058-14. Epub 2015 Feb 17.

3.

A C-reactive protein mutant that does not bind to phosphocholine and pneumococcal C-polysaccharide.

Agrawal A, Simpson MJ, Black S, Carey MP, Samols D.

J Immunol. 2002 Sep 15;169(6):3217-22.

4.
5.

Pneumococcal surface protein A inhibits complement deposition on the pneumococcal surface by competing with the binding of C-reactive protein to cell-surface phosphocholine.

Mukerji R, Mirza S, Roche AM, Widener RW, Croney CM, Rhee DK, Weiser JN, Szalai AJ, Briles DE.

J Immunol. 2012 Dec 1;189(11):5327-35. doi: 10.4049/jimmunol.1201967. Epub 2012 Oct 26.

6.
8.

Site-directed mutagenesis of the phosphocholine-binding site of human C-reactive protein: role of Thr76 and Trp67.

Agrawal A, Lee S, Carson M, Narayana SV, Greenhough TJ, Volanakis JE.

J Immunol. 1997 Jan 1;158(1):345-50.

PMID:
8977209
9.

Purification of recombinant C-reactive protein mutants.

Thirumalai A, Singh SK, Hammond DJ Jr, Gang TB, Ngwa DN, Pathak A, Agrawal A.

J Immunol Methods. 2017 Apr;443:26-32. doi: 10.1016/j.jim.2017.01.011. Epub 2017 Feb 3.

PMID:
28167277
10.

The protective function of human C-reactive protein in mouse models of Streptococcus pneumoniae infection.

Agrawal A, Suresh MV, Singh SK, Ferguson DA Jr.

Endocr Metab Immune Disord Drug Targets. 2008 Dec;8(4):231-7. Review.

11.
12.
13.

C-reactive protein is protective against Streptococcus pneumoniae infection in mice.

Mold C, Nakayama S, Holzer TJ, Gewurz H, Du Clos TW.

J Exp Med. 1981 Nov 1;154(5):1703-8.

14.
16.

Probing the phosphocholine-binding site of human C-reactive protein by site-directed mutagenesis.

Agrawal A, Xu Y, Ansardi D, Macon KJ, Volanakis JE.

J Biol Chem. 1992 Dec 15;267(35):25353-8.

17.

Binding of human serum amyloid P-component to phosphocholine.

Christner RB, Mortensen RF.

Arch Biochem Biophys. 1994 Nov 1;314(2):337-43.

PMID:
7979374
18.

Antipneumococcal effects of C-reactive protein and monoclonal antibodies to pneumococcal cell wall and capsular antigens.

Briles DE, Forman C, Horowitz JC, Volanakis JE, Benjamin WH Jr, McDaniel LS, Eldridge J, Brooks J.

Infect Immun. 1989 May;57(5):1457-64.

19.

The role of the spleen in the protective effect of C-reactive protein in Streptococcus pneumoniae infection.

Nakayama S, Gewurz H, Holzer T, Du Clos TW, Mold C.

Clin Exp Immunol. 1983 Nov;54(2):319-26.

Supplemental Content

Support Center